Skip to main content
. 2009 Jun;11(6):339–344. doi: 10.1089/dia.2008.0107

FIG. 2.

FIG. 2.

Percentage of exenatide- and insulin glargine-treated patients in each ADRR category (Minimal [Min], Low, Moderate [Mod], Moderate-High [Mod-High], and High). The distribution for the risk categories was compared using a nonparametric χ2 test and found to be different overall (P =0.00559). *P < 0.001.